These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38367495)

  • 1. Does size matter? - Comparing pyranoses with septanoses as ligands of the bacterial lectin FimH.
    Cramer J; Pero B; Jiang X; Bosko C; Silbermann M; Rabbani S; Wilke S; Nemli DD; Ernst B; Peczuh MW
    Eur J Med Chem; 2024 Mar; 268():116225. PubMed ID: 38367495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and properties of septanose carbohydrates.
    Saha J; Peczuh MW
    Adv Carbohydr Chem Biochem; 2011; 66():121-86. PubMed ID: 22123189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tyrosine gate as a potential entropic lever in the receptor-binding site of the bacterial adhesin FimH.
    Wellens A; Lahmann M; Touaibia M; Vaucher J; Oscarson S; Roy R; Remaut H; Bouckaert J
    Biochemistry; 2012 Jun; 51(24):4790-9. PubMed ID: 22657089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RMSD analysis of structures of the bacterial protein FimH identifies five conformations of its lectin domain.
    Magala P; Klevit RE; Thomas WE; Sokurenko EV; Stenkamp RE
    Proteins; 2020 Apr; 88(4):593-603. PubMed ID: 31622514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insightful Improvement in the Design of Potent Uropathogenic
    Mousavifar L; Sarshar M; Bridot C; Scribano D; Ambrosi C; Palamara AT; Vergoten G; Roubinet B; Landemarre L; Bouckaert J; Roy R
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interdomain interaction in the FimH adhesin of Escherichia coli regulates the affinity to mannose.
    Aprikian P; Tchesnokova V; Kidd B; Yakovenko O; Yarov-Yarovoy V; Trinchina E; Vogel V; Thomas W; Sokurenko E
    J Biol Chem; 2007 Aug; 282(32):23437-46. PubMed ID: 17567583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational switch of the bacterial adhesin FimH in the absence of the regulatory domain: Engineering a minimalistic allosteric system.
    Rabbani S; Fiege B; Eris D; Silbermann M; Jakob RP; Navarra G; Maier T; Ernst B
    J Biol Chem; 2018 Feb; 293(5):1835-1849. PubMed ID: 29180452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of C-mannosylated anti-adhesives bound to the type 1 fimbrial FimH adhesin.
    de Ruyck J; Lensink MF; Bouckaert J
    IUCrJ; 2016 May; 3(Pt 3):163-7. PubMed ID: 27158502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The price of flexibility - a case study on septanoses as pyranose mimetics.
    Sager CP; Fiege B; Zihlmann P; Vannam R; Rabbani S; Jakob RP; Preston RC; Zalewski A; Maier T; Peczuh MW; Ernst B
    Chem Sci; 2018 Jan; 9(3):646-654. PubMed ID: 29629131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonists.
    Schwardt O; Rabbani S; Hartmann M; Abgottspon D; Wittwer M; Kleeb S; Zalewski A; Smieško M; Cutting B; Ernst B
    Bioorg Med Chem; 2011 Nov; 19(21):6454-73. PubMed ID: 21962988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin.
    Bouckaert J; Berglund J; Schembri M; De Genst E; Cools L; Wuhrer M; Hung CS; Pinkner J; Slättegård R; Zavialov A; Choudhury D; Langermann S; Hultgren SJ; Wyns L; Klemm P; Oscarson S; Knight SD; De Greve H
    Mol Microbiol; 2005 Jan; 55(2):441-55. PubMed ID: 15659162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease.
    Mydock-McGrane LK; Hannan TJ; Janetka JW
    Expert Opin Drug Discov; 2017 Jul; 12(7):711-731. PubMed ID: 28506090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Conformational Variability of FimH: Which Conformation Represents the Therapeutic Target?
    Eris D; Preston RC; Scharenberg M; Hulliger F; Abgottspon D; Pang L; Jiang X; Schwardt O; Ernst B
    Chembiochem; 2016 Jun; 17(11):1012-20. PubMed ID: 26991759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sites for Dynamic Protein-Carbohydrate Interactions of O- and C-Linked Mannosides on the E. coli FimH Adhesin.
    Touaibia M; Krammer EM; Shiao TC; Yamakawa N; Wang Q; Glinschert A; Papadopoulos A; Mousavifar L; Maes E; Oscarson S; Vergoten G; Lensink MF; Roy R; Bouckaert J
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28671638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does targeting Arg98 of FimH lead to high affinity antagonists?
    Tomašič T; Rabbani S; Jakob RP; Reisner A; Jakopin Ž; Maier T; Ernst B; Anderluh M
    Eur J Med Chem; 2021 Feb; 211():113093. PubMed ID: 33340913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 fimbrial adhesin FimH elicits an immune response that enhances cell adhesion of Escherichia coli.
    Tchesnokova V; Aprikian P; Kisiela D; Gowey S; Korotkova N; Thomas W; Sokurenko E
    Infect Immun; 2011 Oct; 79(10):3895-904. PubMed ID: 21768279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary Tract Infection: Which Conformation of the Bacterial Lectin FimH Is Therapeutically Relevant?
    Mayer K; Eris D; Schwardt O; Sager CP; Rabbani S; Kleeb S; Ernst B
    J Med Chem; 2017 Jul; 60(13):5646-5662. PubMed ID: 28471659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approaches to glycomimetic design: development of small molecular weight lectin antagonists.
    Damalanka VC; Maddirala AR; Janetka JW
    Expert Opin Drug Discov; 2021 May; 16(5):513-536. PubMed ID: 33337918
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutation of Tyr137 of the universal
    Rabbani S; Krammer EM; Roos G; Zalewski A; Preston R; Eid S; Zihlmann P; Prévost M; Lensink MF; Thompson A; Ernst B; Bouckaert J
    IUCrJ; 2017 Jan; 4(Pt 1):7-23. PubMed ID: 28250938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic properties of carbohydrate-lectin interactions: FimH antagonists.
    Scharenberg M; Jiang X; Pang L; Navarra G; Rabbani S; Binder F; Schwardt O; Ernst B
    ChemMedChem; 2014 Jan; 9(1):78-83. PubMed ID: 24357503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.